AGENT
Report
- Report Number
- 2124215-2025-78400
- Event Type
- Injury
- Date Received
- October 31, 2025
- Date of Event
- March 25, 2025
- Report Date
- October 31, 2025
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- OOB
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
DETAILED PRODUCT INFORMATION WAS NOT PROVIDED TO BSC. BECAUSE THE PRODUCT IS UNKNOWN, WE ARE UNABLE TO PROVIDE THE UNIQUE IDENTIFIER (UDI) # AND OTHER SPECIFIC PRODUCT INFORMATION.
IT WAS REPORTED THAT RESTENOSIS OCCURRED. ON (B)(6) 2025, THE PATIENT PRESENTED TO HOSPITAL WITH SHORTNESS OF BREATH AND CHEST PRESSURE. AT THE TIME OF EVENT, THE PATIENT WAS ON ASPIRIN AND CLOPIDOGREL WHICH WERE CONTINUED. THE PATIENT WAS DIAGNOSED WITH RECURRENT ANGINA. DIAGNOSTIC CORONARY ANGIOGRAPHY REVEALED 80% IN STENT RESTENOSIS (ISR) AT THE RIGHT CORONARY ARTERY (RCA). THE OSTIAL LESION WAS SUCCESSFULLY TREATED WITH 3.50 MM X 30 MM AND 3.00 MM X 12 MM AGENT DCB BALLOONS SUCCESSFULLY. DURING THE SAME PROCEDURE, IN STENT RESTENOSIS AT THE MID-DISTAL RCA WAS TREATED WITH A 3.50 MM X 20 MM AGENT DCB DEVICE. POST REVASCULARIZATION, THE RESIDUAL STENOSIS WAS NOTED AS 0% AND TIMI FLOW WAS 3. ON (B)(6) 2025, 70% IN-STENT RESTENOSIS AT THE MID RCA WAS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION DEVICES. POST REVASCULARIZATION, THE RESIDUAL STENOSIS WAS NOTED AS 0% AND TIMI FLOW WAS 3. THE EVENT WAS CONSIDERED TO BE RESOLVED/RECOVERED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2085605 | AGENT | DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER | OOB | BOSTON SCIENTIFIC CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Male | Required Intervention |